Daniel P. Getman
Direktor/Vorstandsmitglied bei KaloCyte, Inc.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Dipanjan Pan | M | - |
KaloCyte, Inc.
KaloCyte, Inc. BiotechnologyHealth Technology Kalocyte, Inc. operates as a pre-clinical stage healthcare biotech company. It provides artificial red blood cell substitutes used for trauma care related services. The company was founded in 2016 and is headquartered in Baltimore, MD. | 8 Jahre |
Philip Spinella | M | - |
KaloCyte, Inc.
KaloCyte, Inc. BiotechnologyHealth Technology Kalocyte, Inc. operates as a pre-clinical stage healthcare biotech company. It provides artificial red blood cell substitutes used for trauma care related services. The company was founded in 2016 and is headquartered in Baltimore, MD. | 8 Jahre |
Allan Doctor | M | - |
KaloCyte, Inc.
KaloCyte, Inc. BiotechnologyHealth Technology Kalocyte, Inc. operates as a pre-clinical stage healthcare biotech company. It provides artificial red blood cell substitutes used for trauma care related services. The company was founded in 2016 and is headquartered in Baltimore, MD. | 8 Jahre |
Elaine Haynes | F | - |
KaloCyte, Inc.
KaloCyte, Inc. BiotechnologyHealth Technology Kalocyte, Inc. operates as a pre-clinical stage healthcare biotech company. It provides artificial red blood cell substitutes used for trauma care related services. The company was founded in 2016 and is headquartered in Baltimore, MD. | 6 Jahre |
William Barlow Neaves | M | 80 |
Washington University School of Medicine
| - |
Daniel S. Ory | M | - |
Washington University School of Medicine
| - |
Ronald Rubenstein | M | - |
Washington University School of Medicine
| - |
Carolyn Baum | F | - |
Washington University School of Medicine
| - |
Barbara Warner | F | - |
Washington University School of Medicine
| - |
Wayne Yokoyama | M | - |
Washington University School of Medicine
| - |
Lila Solnica-Krezel | F | - |
Washington University School of Medicine
| - |
Tom Krenning | M | - |
KaloCyte, Inc.
KaloCyte, Inc. BiotechnologyHealth Technology Kalocyte, Inc. operates as a pre-clinical stage healthcare biotech company. It provides artificial red blood cell substitutes used for trauma care related services. The company was founded in 2016 and is headquartered in Baltimore, MD. | 7 Jahre |
John Dipersio | M | - |
Washington University School of Medicine
| - |
Brian Estes | M | - |
KaloCyte, Inc.
KaloCyte, Inc. BiotechnologyHealth Technology Kalocyte, Inc. operates as a pre-clinical stage healthcare biotech company. It provides artificial red blood cell substitutes used for trauma care related services. The company was founded in 2016 and is headquartered in Baltimore, MD. | - |
Kelvin Westbrook | M | 68 |
Washington University School of Medicine
| - |
Nico Dosenbach | M | - |
Washington University School of Medicine
| - |
Michael J. Hart | M | - |
Washington University School of Medicine
| - |
John M. Forbes | M | - |
KaloCyte, Inc.
KaloCyte, Inc. BiotechnologyHealth Technology Kalocyte, Inc. operates as a pre-clinical stage healthcare biotech company. It provides artificial red blood cell substitutes used for trauma care related services. The company was founded in 2016 and is headquartered in Baltimore, MD. | - |
William A. Frazier | M | - |
Washington University School of Medicine
| - |
Richard G. Ganz | M | 66 |
KaloCyte, Inc.
KaloCyte, Inc. BiotechnologyHealth Technology Kalocyte, Inc. operates as a pre-clinical stage healthcare biotech company. It provides artificial red blood cell substitutes used for trauma care related services. The company was founded in 2016 and is headquartered in Baltimore, MD. | - |
Lee F. Fetter | M | - |
Childrens Discovery Institute
| - |
Wayne Carter | M | - |
Kansas City Area Life Sciences Institute, Inc.
| 12 Jahre |
Richard Whitley | M | 78 |
Washington University School of Medicine
| - |
Samuel Wickline | M | 71 |
Washington University School of Medicine
| - |
Meg Wood | F | - |
KaloCyte, Inc.
KaloCyte, Inc. BiotechnologyHealth Technology Kalocyte, Inc. operates as a pre-clinical stage healthcare biotech company. It provides artificial red blood cell substitutes used for trauma care related services. The company was founded in 2016 and is headquartered in Baltimore, MD. | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Jeff W. Craver | M | - |
Missouri Biotechnology Association
| 2 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 26 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Daniel P. Getman
- Persönliches Netzwerk